Articles  |   September 2011
DEA Proposes Reclassification of Propofol as a Schedule IV Controlled Substance: What Might That Mean for Anesthesiologists?
Author Affiliations
  • Jonathan D. Katz, M.D.
    Committee on Occupational Health
  • Donald E. Martin, M.D.
    Section on Clinical Care
    Chair
  • Robert S. Holzman, M.D., F.A.A.P.
    Committee on Occupational Health
    Chair
Article Information
Articles
Articles   |   September 2011
DEA Proposes Reclassification of Propofol as a Schedule IV Controlled Substance: What Might That Mean for Anesthesiologists?
ASA Monitor 09 2011, Vol.75, 44-86.
ASA Monitor 09 2011, Vol.75, 44-86.
This content is PDF only. Please click on the PDF icon to access.
First Page Preview
First page PDF preview
First page PDF preview ×
View Large
0 Comments
Submit a Comment
Submit A Comment

Contributors must reveal any conflict of interest. Comments are moderated.

Name
Affiliation & Institution
I have a potential conflict of interest
Comment Title
Comment


This feature is available to Subscribers Only
ASA Member Login or Create an Account ×